To investigate the presence of α-defensin-1 in ischemic stroke thrombi and its role in inducing NETosis.
Key Findings:
α-Defensin-1 was detected in all analyzed thrombi, predominantly in regions enriched with neutrophils.
NETs were prominently featured in thrombi, as shown by citrullinated histone H3 staining.
Exposure to recombinant α-defensin-1 significantly increased NETosis at 10 µg/mL compared to unstimulated controls.
Interpretation:
α-Defensin-1 is a structural component of stroke thrombi and induces NETosis in vitro, indicating a link between neutrophil degranulation and thrombus composition.
Limitations:
Study involved a small sample size of 6 patients.
In vitro findings may not fully replicate in vivo conditions.
Conclusion:
α-Defensin-1 may play a significant role in the composition of stroke thrombi and the induction of NETosis.
Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.
